Combined analysis of phase III trials evaluating [99mTc] tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma
Vernon K. Sondak*, Dennis W. King, Jonathan S. Zager, Schlomo Schneebaum, Julian Kim, Stanley P.L. Leong, Mark B. Faries, Bruce J. Averbook, Steve R. Martinez, Christopher A. Puleo, Jane L. Messina, Lori Christman, Anne M. Wallace
Research output: Contribution to journal › Article › peer-review
117Scopus
citations
Fingerprint
Dive into the research topics of 'Combined analysis of phase III trials evaluating [99mTc] tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma'. Together they form a unique fingerprint.